Two studies reported that BMI1 protein expression in primary tumor tissue is not a significant prognostic factor in NSCLC patients [24, 27], whereas the results of two groups showed that high BMI1 protein expression is associated with unfavorable survival of patients with operable NSCLC [28, 29]. The gene discussed is BMI1; the disease is neoplasm.